Cassandra Pardini, PharmD

Contributing Writer

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

If you prescribe opioids, inform your patients how to safeguard them. A locked cabinet or medicine safe box can ensure that only the patient has access. Should your patient no longer choose to use opioids, he or she can safely dispose of them through a drug take-back location, such as a local pharmacy or law enforcement.

News

Evidence to Support Suicidality Warning for Newer Antiseizure Meds Lacking

Cassandra Pardini, PharmD

August 11, 2021

The analysis included 5 antiseizure medications (eslicarbazepine, perampanel, brivaracetam, cannabidiol, and cenobamate) evaluated in 17 randomized clinical trials.

News

Study Shows Loneliness Tied to Use of High-Risk Medications

Cassandra Pardini, PharmD

August 3, 2021

The study authors utilized the National Social Life, Health, and Aging Project leave-behind questionnaire to obtain data on a total of 6017 adults over 65 years of age.

News

Study Supports Shorter Antibiotic Course for Afebrile Men With UTI

Cassandra Pardini, PharmD

July 27, 2021

The double-blinded, placebo-controlled noninferiority study included a total of 272 afebrile men from 2 US Veterans Affairs medical centers.

News

ACE Inhibitors vs ARBs for First-Line Hypertension Treatment

Cassandra Pardini, PharmD

July 26, 2021

Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines.

News

Coffee Consumption and Arrhythmia Risk: What’s the Link?

Cassandra Pardini, PharmD

July 22, 2021

Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.

News

Lithium Compared With Newer Therapies as Adjunct to Antidepressants

Cassandra Pardini, PharmD

July 20, 2021

The likelihood of help or harm, also known as the risk/benefit ratio, was found to be more favorable for lithium.

News

Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored

Cassandra Pardini, PharmD

July 14, 2021

Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.

News

Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma

Cassandra Pardini, PharmD

July 2, 2021

Data mining resulted in 2006 reports of anaphylaxis related to the use of 5 mAbs.

News

Risk of Muscle Problems Based on Statin Therapy Intensity Investigated

Cassandra Pardini, PharmD

June 24, 2021

Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.

News

Medication Organizers Often Contain “One Pill Can Kill” Meds

Cassandra Pardini, PharmD

May 26, 2021

While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.

Next post in News